Applicant, as named in the Orange Book

Twi Pharms

Next listed expiry: Forfivo Xl on 23 Aug 2028. 1 products with live protection, 3 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Forfivo Xl bupropion hydrochloride	bupropion hydrochloride	022497	23 Aug 2028	patent

Products without listed protection (3)

Drug	Ingredient	NDA	Earliest generic entry	Basis
Naprelan · 3 strengths naproxen sodium	naproxen sodium	020353	open now	no listed protection
Tenormin · 3 strengths atenolol	atenolol	018240	open now	no listed protection
Zestril · 6 strengths lisinopril	lisinopril	019777	open now	no listed protection